Recruiting Validation of RCC Predicting Model With Emulated-target Trial NCT07117227 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more Locations Peking University Third Hospital — Beijing, Beijing Municipality, China View Trial Details
Recruiting TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT NCT05984511 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more Locations The Third Affiliated Hospital of Sun Yat-Sen University — Guangzhou, China View Trial Details
Recruiting Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion NCT05589207 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more Locations Peking University Third Hospital — Beijing, Beijing Municipality, China View Trial Details
